A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI TherapyJiangdian Song, Jie Tian, Mengjie Fang et al.|Clinical Cancer Research|2018Cited by 198
Diminishing microbiome richness and distinction in the lower respiratory tract of lung cancer patients: A multiple comparative study design with independent validationJing Jin, Yuncui Gan, Huayong Liu et al.|Lung Cancer|2019Cited by 102